User: Guest  Login
Title:

The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma - A systematic review and meta-analysis.

Document type:
Journal Article; Review
Author(s):
Schorn, Stephan; Demir, Ihsan Ekin; Haller, Bernhard; Scheufele, Florian; Reyes, Carmen Mota; Tieftrunk, Elke; Sargut, Mine; Goess, Ruediger; Friess, Helmut; Ceyhan, Güralp Onur
Abstract:
To assess the impact of neural invasion/NI on overall survival/OS and tumor recurrence in pancreatic ductal adenocarcinoma/PDAC.NI is a histopathological hallmark of PDAC. Although some studies suggested an important role for NI on OS, disease-free/DFS and progression-free survival/PFS in PDAC, there is still no consensus on the actual role of NI on survival and local recurrence in PDAC.Pubmed, Cochrane library, Ovid and Google Scholar were screened for the terms "pancreatic ductal adenocarcinoma", "pancreatic cancer", "survival", "tumor recurrence" and "perineural invasion". The Preferred-Reporting-Items-for-Systematic-review-and-Meta-Analysis/PRISMA-guidelines were used for systematic review and meta-analysis. Articles meeting predefined criteria were critically analysed on relevance, and meta-analyses were performed by pooling univariate and multivariate hazard ratios/HR.A total number of 25 studies on the influence of NI on tumor recurrence, and 121 studies analysing the influence of NI on survival were identified by systematic review. The HR of the univariate (HR 1.88; 95%-CI 1.71-2.07; p < 0.00001) and multivariate meta-analysis (HR 1.68; 95%-CI 1.47-1.92; p < 0.00001) showed a major impact of NI on OS. Likewise, NI was associated with decreased DFS (HR 2.53; 95%-CI: 1.67-3.83; p = 0.0001) and PFS (HR 2.41; 95%-CI: 1.73-3.37: p < 0.00001) multivariate meta-analysis.Although the power of this study is limited by missing pathological procedures to assess the true incidence of NI, NI appears to be an independent prognostic factor for OS, DFS and PFS in PDAC. Therefore, NI should be increasingly considered in patient stratification and in the development of novel therapeutic algorithms.
Journal title abbreviation:
Surg Oncol
Year:
2017
Journal volume:
26
Journal issue:
1
Pages contribution:
105-115
Language:
eng
Fulltext / DOI:
doi:10.1016/j.suronc.2017.01.007
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/28317579
Print-ISSN:
0960-7404
TUM Institution:
Chirurgische Klinik und Poliklinik; Institut für Medizinische Statistik und Epidemiologie
 BibTeX